Nurse Practitioner, Psychiatric/Mental Health · Bedford, TX
NPI
1821157363
Since 2006
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1604 Hospital Pkwy, #507
Bedford, TX, 76022
Phone (817) 354-7268
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$198K
984 prescriptions
Company payments, 2025
$2,919
From 23 companies
Medicare prescription drug claims, 2024
In 2024, the drug Christine K Wysong prescribed most often to Medicare patients was Alprazolam, with 130 prescriptions and refills. In total Christine K Wysong wrote 984 Medicare prescriptions that cost $198K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Alprazolam Generic | 130 | 141 | 18 | $771 |
| Lamotrigine Generic | 74 | 134 | 15 | $963 |
| Bupropion Xl Bupropion Hcl | 73 | 166 | 17 | $1,958 |
| Clonazepam Generic | 56 | 64 | Under 11 | $327 |
| Lorazepam Generic | 50 | 53 | Under 11 | $326 |
| Escitalopram Oxalate Generic | 49 | 103 | 11 | $708 |
| Gabapentin Generic | 45 | 65 | Under 11 | $576 |
| Duloxetine Hcl Generic | 33 | 41 | Under 11 | $228 |
| Aripiprazole Generic | 27 | 42 | Under 11 | $4,869 |
| Trazodone Hcl Generic | 26 | 56 | Under 11 | $349 |
| Lurasidone Hcl Generic | 24 | 36 | Under 11 | $3,663 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 23 | 43 | Under 11 | $1,085 |
| Vraylar Cariprazine Hcl | 20 | 24 | Under 11 | $33K |
| Sertraline Hcl Generic | 20 | 36 | Under 11 | $243 |
| Buspirone Hcl Generic | 19 | 29 | Under 11 | $133 |
Brand drugs: - claims; generic drugs: 886 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christine K Wysong $2,919 ($2,919 in general payments such as food, travel and fees) from 23 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $348.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 14 | $348 |
| Axsome Therapeutics, Inc. AXSM | 10 | $329 |
| Neurocrine BioSciences, Inc. NBIX | 14 | $311 |
| Tris Pharma Inc | 2 | $250 |
| Bausch Health US, LLC BHC | 14 | $242 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 13 | $241 |
| Teva Pharmaceuticals USA, Inc. TEVA | 7 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $137 |
| Vanda Pharmaceuticals Inc. VNDA | 7 | $134 |
| Alkermes, Inc. ALKS | 5 | $128 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.